Recombinant Human GJA1 Protein，His

GJA1, also known as connexin 43 (Cx43), is a pivotal protein involved in intercellular communication through gap junctions, facilitating the direct transfer of ions and small molecules between adjacent cells. Its role is crucial in various physiological processes, including cardiac and skeletal muscle function, as well as in embryonic development. Research has indicated that aberrations in GJA1 expression or function can lead to several pathologies, including cardiac arrhythmias, vascular diseases, and even certain types of cancer. In the context of regenerative medicine, GJA1 has attracted attention for its potential to enhance tissue repair and regeneration, especially in heart tissues post-infarction. Recombinant GJA1 proteins can be used in studies to elucidate the mechanisms of gap junction intercellular communication and to investigate how alterations in this communication can affect cellular behavior in health and disease. Moreover, producing GJA1 as a recombinant protein allows for controlled studies on its functional properties, interactions with other proteins, and its implications in cell signaling pathways. This research is vital for developing potential therapeutic strategies aimed at restoring normal gap junction communication in diseased tissues and advancing our understanding of cellular communication's role in health and disease. Therefore, the study of GJA1 recombinant proteins represents a significant area of investigation in cellular biology and therapeutic development.